long-term effects of glp-1 medications are changing obesity treatment. But the research on is still catching up. Stay informed. The science is moving fast. #HealthTrend #HealFrontier #GLP1 #ObesityTreatment #ModernMedicine #HealthInnovation #ClinicalInsights 6 Common Side Effects of

Starting doses vary by medication: semaglutide (Ozempic/Wegovy) begins at 0.25 mg weekly, dulaglutide (Trulicity) at 0.75 mg weekly, and liraglutide (Victoza/Saxenda) at 0.6 mg daily

If you are on combination therapy and plan to take your GLP-1 dose early, monitor your blood sugar more frequently that day

Safety profile observations: Gastrointestinal adverse events remained the primary side effect category, consistent with other incretin-based therapies

doi 10.1210/me.2004-0196 65 WalshNAYustaBDaCambraMPAniniYDruckerDJBrubakerPL

GLP-1s come in both injectable and oral forms

The longer GLP1 stays active, the stronger the appetite suppression and GI slowing, so you feel fuller faster and longer, reducing food and therefore calorie intake